A total of 81 individuals were included in our study: 26 healthy individuals (MetS–), 29 with metabolic syndrome and hypertension but normal ALT levels (MetS+ HTN+ ALT–), and 26 with MetS, hypertension and elevated ALT levels (MetS+ HTN+ ALT+). This evidence concerns the gene GPT and metabolic syndrome.